SUBSCRIBE
SUBSCRIBE

Sage Therapeutics

Amneal and Impax to Marry, Creating the 5th Larges
Biotech Bay
Top 3 Biotech Stocks to Buy in 2018
Here’s a look at three promising biotech stocks.
December 7, 2017
 · 
3 min read
3 Biotechs That Got Huge Boosts From Spark's FDA P
Drug Development
Sage Therapeutics Erupts as Depression Drug Wows in Mid-Stage Study
Shares of Sage have shot up more than 75 percent this morning as a result of the impressive data.
December 7, 2017
 · 
2 min read
 · 
Alex Keown
Roche Could Take a $500M Hit Over Patent Losses
Biotech Bay
Sage Therapeutics Fills Its Pockets
Sage Therapeutics has been on a roll with good news lately.
November 27, 2017
 · 
1 min read
 · 
Karl Thiel
Ignyta Stock Booms on Promising Mid-Stage Lung Can
Drug Development
ASH Heats Up, Plus Alkermes’ Huge I-Told-Ya-So
The drug developed by Alkermes took a lot of flack but proved effective in a recent study.
November 27, 2017
 · 
1 min read
 · 
Karl Thiel
Drug Development
Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression
The positive results support the company’s planned regulatory submissions.
November 9, 2017
 · 
2 min read
 · 
Mark Terry
Drug Development
Does SAGE Therapeutics’ Failure Predict Its Future Results?
September 13, 2017
 · 
1 min read
SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test
Drug Development
SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test
September 12, 2017
 · 
2 min read
Drug Development
SAGE Therapeutics Takes Investors On A Wild Ride As CEO Talks Up Brain Drugs
February 22, 2017
 · 
1 min read
SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test
Business
SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity
February 17, 2017
 · 
2 min read
Load More
AWARDS
  • 2024 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Genetown
Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 In Depth
May 13, 2021
 · 
4 min read
Business
Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
May 4, 2021
 · 
23 min read
Genetown
Sage Therapeutics to Present at Upcoming May Investor Conferences
April 28, 2021
 · 
1 min read
Business
Sage Therapeutics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
April 20, 2021
 · 
1 min read
Business
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
April 12, 2021
 · 
15 min read
Genetown
Sage Therapeutics to Present at the Stifel 3rd Annual CNS Day
March 24, 2021
 · 
1 min read
Genetown
Sage Therapeutics Announces Continued Positive Zuranolone Data for Both 30 mg and 50 mg Doses in Open-Label SHORELINE Study in Patients with MDD
March 17, 2021
 · 
11 min read
Business
Sage Therapeutics Announces Departure of Chief Operating Officer
March 16, 2021
 · 
4 min read
Business
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
February 24, 2021
 · 
23 min read
Genetown
Sage Therapeutics to Present at Upcoming Investor Conferences
February 11, 2021
 · 
1 min read
Load More